Severe Sepsis: The Fragile Anatomy of Crude Mortality

Area of Science:

• Critical care medicine
• Clinical trial design
• Epidemiology

Background:

• Clinical trials investigating severe sepsis frequently target crude mortality rates.
• Such trials are often statistically underpowered to detect meaningful differences attributable to specific interventions.
• This limitation hinders the evaluation of treatment efficacy in severe sepsis.

Purpose of the Study:

• To highlight the inadequacy of targeting crude mortality in severe sepsis clinical trials.
• To emphasize the importance of incorporating subcomponents of crude mortality into study designs.
• To discuss the impact of attributable mortality proportions on sample size calculations and outcome interpretation.

Main Methods:

• This study involves a discussion and analysis of statistical power in clinical trials.
• It examines the relationship between attributable mortality and sample size requirements.
• The interpretation of minor outcome variations in the context of predicted results is also discussed.

Main Results:

• Crude mortality targets in severe sepsis trials are insufficient for detecting intervention-related differences.
• The proportion of attributable mortality significantly influences the necessary sample size for clinical trials.
• Even small deviations from predicted outcomes can complicate the interpretation of trial results.

Conclusions:

• Future severe sepsis clinical trials should incorporate subcomponents of crude mortality for improved statistical power.
• Accurate sample size calculations are dependent on understanding attributable mortality.
• Careful consideration of outcome interpretation is essential for advancing severe sepsis treatment.